论文部分内容阅读
目的探讨超声引导下两种不同的聚桂醇注射方法在肝血管瘤硬化治疗中的临床疗效。方法 42例(50个病灶)经超声造影或核磁共振明确诊断的肝血管瘤患者,随机分为泡沫组(21例,26个病灶),行聚桂醇泡沫注射硬化治疗;原液组(21例,24个病灶)行聚桂醇原液硬化治疗。通过观察治疗前及治疗后的两组病例患者瘤体大小(测量两组病例术前及术后的病灶最大长径、面积)来评价两种治疗方式的效果。结果 42例患者均顺利实施硬化治疗。泡沫组与原液组患者治疗前后3、6个月血管瘤最大长径,最大面积对比均无明显统计学差异,治疗3、6个月的有效率分别为50.00%、53.84%和54.17%、54.17%。两组患者治疗中及治疗后均未发生严重的并发症。结论两种聚桂醇注射方式在硬化治疗肝血管瘤中均安全有效且效果相当。
Objective To investigate the clinical effects of ultrasound-guided two different methods of injection of lauromacyl alcohol in the treatment of hepatic hemangioma sclerosis. Methods 42 patients (50 lesions) with hepatic hemangiomas diagnosed by contrast echocardiography or magnetic resonance imaging were randomly divided into foam group (21 cases, 26 lesions) treated with lauromacyl alcohol foam injection. In the untreated group (21 cases , 24 lesions) line of Lauryl alcohol sclerosis treatment. The effects of the two treatment methods were evaluated by observing the tumor size of the two groups of patients before and after treatment (measuring the maximum diameter and area of the lesion before and after the operation in both groups). Results 42 patients were successfully treated with sclerotherapy. There was no significant difference in maximal diameter and maximal area of hemangiomas between 3 and 6 months before and after treatment in the foam group and the original liquid group. The effective rates at 3 and 6 months after treatment were 50.00%, 53.84% and 54.17%, 54.17% %. Two groups of patients during and after treatment did not occur serious complications. Conclusion Both of the two lauromacrogol injection methods are effective and safe in the treatment of hepatic hemangiomas.